A CTB-SARS-CoV-2-ACE-2 RBD Mucosal Vaccine Protects Against Coronavirus Infection

A CTB-SARS-CoV-2-ACE-2 RBD Mucosal Vaccine Protects Against Coronavirus Infection

Mucosal vaccines protect against respiratory virus infection by stimulating the production of IgA antibodies that protect against virus invasion of the mucosal epithelium. In this study, a novel protein subunit mucosal vaccine was constructed for protection against infection by the beta coronavirus...

Full description

Bibliographic Details
Main Authors:	Béla Dénes, Ryan N. Fuller, Wayne Kelin, Tessa R. Levin, Jaipuneet Gil, Aaren Harewood, Márta Lőrincz, Nathan R. Wall, Anthony F. Firek, William H. R. Langridge
Format:	Article
Language:	English
Published:	MDPI AG 2023-12-01
Series:	Vaccines
Subjects:	beta coronaviruses SARS-CoV-2 COVID-19 virus neutralization sIgA mucosal immunization
Online Access:	https://www.mdpi.com/2076-393X/11/12/1865

Similar Items

Human Mucosal IgA Immune Responses against Enterotoxigenic <i>Escherichia coli</i>
by: Saman Riaz, et al.
Published: (2020-08-01)

Mucosal Immunity and the Gut-Microbiota-Brain-Axis in Neuroimmune Disease
by: Kathryn G. Sterling, et al.
Published: (2022-11-01)

Mucosal immune responses and protective efficacy elicited by oral administration AMP-ZnONPs-adjuvanted inactivated H9N2 virus in chickens
by: Xiaopan Liu, et al.
Published: (2024-04-01)

Differences in Humoral Immune Response against the Type 2 Porcine Reproductive and Respiratory Syndrome Virus via Different Immune Pathways
by: Wen Li, et al.
Published: (2022-06-01)

Polysaccharide from <i>Atractylodes macrocephala</i> Koidz Binding with Zinc Oxide Nanoparticles as a Novel Mucosal Immune Adjuvant for H9N2 Inactivated Vaccine
by: Xiaopan Liu, et al.
Published: (2024-02-01)

Production and Purification of LTB-RBD: A Potential Antigen for Mucosal Vaccine Development against SARS-CoV-2
by: Karla I. Solis-Andrade, et al.
Published: (2022-10-01)

Towards Development of a Non-Toxigenic <i>Clostridioides difficile</i> Oral Spore Vaccine against Toxigenic <i>C. difficile</i>
by: Jaime Hughes, et al.
Published: (2022-05-01)

A new hope? Possibilities of therapeutic IgA antibodies in the treatment of inflammatory lung diseases
by: Fabian Bohländer
Published: (2023-03-01)

Changes in nasal, pharyngeal and salivary secretory IgA levels in patients with COVID-19 and the possibility of correction of their secretion using combined intranasal and oral administration of a pharmaceutical containing antigens of opportunistic microorganisms
by: Mikhail Kostinov, et al.
Published: (2023-06-01)

Pengaruh Pemberian Kolostrum Susu Sapi Terhadap Durasi Diare Akut Dehidrasi Ringan Sedang dan Kadar Sekretori Imunoglobulin A pada Anak
by: Alfi Maido Alius, et al.
Published: (2023-04-01)

DYNAMICS OF SIgA CONTENT IN BREAST MILK WHEN RISK FACTORS AND LACTATIONAL CHARACTERISTICS ARE CONSIDERED
by: Nataliya Gromnatska
Published: (2022-06-01)

Sekretori Immunoglobulin A Kolostrum Berhubungan dengan Infeksi dan Infeksi Saluran Pernapasan Atas pada Bayi Usia Tiga Tahun: Studi Prospektif
by: Sri Priyantini, et al.
Published: (2023-02-01)

Mucosal antibody responses to SARS-CoV-2 booster vaccination and breakthrough infection
by: Disha Bhavsar, et al.
Published: (2023-12-01)

Colonisation Factor CD0873, an Attractive Oral Vaccine Candidate against <i>Clostridioides difficile</i>
by: Cansu Karyal, et al.
Published: (2021-02-01)

Intestinal fungi and antifungal secretory immunoglobulin A in Crohn’s disease
by: Meng Sun, et al.
Published: (2023-06-01)

Shared and Non-Shared sIgA-Coated and -Uncoated Bacteria in Intestine of Mother–Infant Pairs
by: Mengfan Ding, et al.
Published: (2022-08-01)

UMA PESQUISA SOBRE FERRAMENTAS CASE PARA ENGENHARIA REVERSA ESTÁTICA
by: Juliana da Silva Cindra, et al.
Published: (2011-05-01)

Safety and immunogenicity of heterologous boosting with orally administered aerosolized bivalent adenovirus type-5 vectored COVID-19 vaccine and B.1.1.529 variant adenovirus type-5 vectored COVID-19 vaccine in adults 18 years and older: a randomized, double blinded, parallel controlled trial
by: Jia-Wei Xu, et al.
Published: (2024-12-01)

Impact of Biometric Patient Data, Probiotic Supplementation, and Selected Gut Microorganisms on Calprotectin, Zonulin, and sIgA Concentrations in the Stool of Adults Aged 18–74 Years
by: Magdalena Jendraszak, et al.
Published: (2022-11-01)

Vaccine Strategies to Elicit Mucosal Immunity
by: Yufeng Song, et al.
Published: (2024-02-01)

Dynamics of clinical symptoms and secretory immunoglobulin a in COVID-19 convalescent patients
by: Albina А. Khasanova, et al.
Published: (2022-12-01)

Editorial: Mucosal vaccines for the induction of antimicrobial immunoglobulin A
by: Reiko Shinkura
Published: (2024-02-01)

Üç Boyutlu Baskı Metodu ile Üretilmiş Dalgalı Yüzeyli Sığal Basınç Algılayıcı
by: Yiğit Dağhan Gökdel, et al.
Published: (2019-07-01)

Alteration of microbiota antibody‐mediated immune selection contributes to dysbiosis in inflammatory bowel diseases
by: Eva Michaud, et al.
Published: (2022-08-01)

KUR’AN’DA FİİLİ TAACCÜP
by: Muzaffer Özli
Published: (2020-12-01)

THE ROLE OF SALIVARY IMMUNOGLOBULIN A IN THE PREVENTION OF THE UPPER RESPIRATORY TRACT INFECTIONS IN ATHLETES – AN OVERVIEW
by: Joanna Orysiak, et al.
Published: (2012-11-01)

Gastrointestinal Mucosal Barrier and Standardization of the Application of Mucosal Protective Agents: Interpretation on the Consensus of Clinical Experts on Gastrointestinal Mucosal Protection(2021, Fuzhou)
by: LI Jingnan
Published: (2022-09-01)

Mucosal Injury during Anti-Cancer Treatment: From Pathobiology to Bedside
by: Debora Basile, et al.
Published: (2019-06-01)

The Mucoadhesive Nanoparticle-Based Delivery System in the Development of Mucosal Vaccines
by: Zhao K, et al.
Published: (2022-09-01)

Principles of mucosal immunology /
by: Smith, Phillip D., M.D. 544928, et al.
Published: (2013)

Role of cyclooxygenases 1 and 2 in the maintenance of colonic mucosal integrity in an experimental colitis model
by: H.B. Costa-Filho, et al.
Published: (2023-10-01)

Modified Sijunzi granule decreases post-weaning diarrhea in Rex rabbits via promoting intestinal development
by: Dongbo Li, et al.
Published: (2022-11-01)

Mucosal vaccine delivery: A focus on the breakthrough of specific barriers
by: Mengwen Huang, et al.
Published: (2022-09-01)

Nano selenium-enriched probiotic Lactobacillus enhances alum adjuvanticity and promotes antigen-specific systemic and mucosal immunity
by: Runhang Liu, et al.
Published: (2023-01-01)

Mucosal vaccination: onward and upward
by: Catherine J. Y. Tsai, et al.
Published: (2023-12-01)

Hacking Commensal Bacteria to Consolidate the Adaptive Mucosal Immune Response in the Gut–Lung Axis: Future Possibilities for SARS-CoV-2 Protection
by: Marcela Pereira, et al.
Published: (2022-01-01)

Oral vaccination with recombinant Lactobacillus casei expressing Aha1 fused with CTB as an adjuvant against Aeromonas veronii in common carp (Cyprinus carpio)
by: Chong Chen, et al.
Published: (2022-06-01)

Mucosal bridge due to reflux esophagitis
by: Keiichiro Kume, et al.
Published: (2009-10-01)

Progress and challenges in the clinical evaluation of immune responses to respiratory mucosal vaccines
by: Xuanxuan Zhang, et al.
Published: (2024-12-01)

A Glance at the Development and Patent Literature of Tecovirimat: The First-in-Class Therapy for Emerging Monkeypox Outbreak
by: Mazen Almehmadi, et al.
Published: (2022-08-01)